As of March 2024 Akebia Therapeutics has a market cap of $0.38 Billion. This makes Akebia Therapeutics the world's 6318th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.38 B | 64.02% |
2023 | $0.23 B | 120.08% |
2022 | $0.10 B | -73.16% |
2021 | $0.39 B | -2.3% |
2020 | $0.40 B | -47.37% |
2019 | $0.76 B | 18.97% |
2018 | $0.64 B | -8.04% |
2017 | $0.70 B | 76.18% |
2016 | $0.39 B | 0.71% |
2015 | $0.39 B | 67.07% |
2014 | $0.23 B |
On Mar 28th, 2024 the market cap of Akebia Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $381.20 B | 99,391.66% | ๐บ๐ธ USA |
Novartis NVS | $197.71 B | 51,503.45% | ๐จ๐ญ Switzerland |
Amgen AMGN | $153.47 B | 39,955.09% | ๐บ๐ธ USA |
Nektar Therapeutics
NKTR | $0.17 B | -55.23% | ๐บ๐ธ USA |